Design, synthesis and evaluation of the Brigatinib analogues as potent inhibitors against tertiary EGFR mutants (EGFRdel19/T790M/C797S and EGFRL858R/T790M/C797S)
- Resource Type
- Short Communication
- Source
- In
Bioorganic & Medicinal Chemistry Letters 15 September 2022 72 - Subject
- Language
- ISSN
- 0960-894X